{"ctNumber":"2025-524939-39-02","ctStatus":"Authorised","decisionDate":"2026-08-01T02:10:00.347","publishDate":"2026-08-02T03:30:53.139067183","ctPublicStatusCode":2,"authorizedApplication":{"authorizedPartI":{"id":137602,"rowSubjectCount":0,"products":[{"id":572967,"part1MpRoleTypeCode":"1","productDictionaryInfo":{"productPk":"13947476","productPharmForm":"CAPSULES","euMpNumber":"PRD13947476","prodAuthStatus":1,"prodName":"PEX010","pharmForm":"CAPSULES","activeSubstanceName":"DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL","euSubstNumber":"SUB267722","nameOrg":"REGION SJAELLAND","productSubstances":[{"productPk":"13947476","substancePk":"377754","nameOrg":"REGION SJAELLAND","substanceOrigin":"Specified Substance Group 1","actSubstOrigin":"Specified Substance Group 1","actSubstName":"DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL","substanceEvCode":"SUB267722"}],"activeSubstanceOtherDescriptiveName":""},"isPaediatricFormulation":false,"mpRoleInTrial":"1","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"25","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"50","maxTreatmentPeriod":2,"timeUnitCode":"1","evCode":"PRD13947476","miaNumber":"244/0575/18","devices":[],"characteristics":["2"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PEX010","jsonActiveSubstanceNames":"dry extract from psilocybe cubensis (15-25:1), extraction solvent: methanol","pharmaceuticalFormDisplay":"CAPSULES"}],"trialDetails":{"clinicalTrialIdentifiers":{"fullTitle":"The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT). A Randomised, Active-Placebo-Controlled, Triple-blind, Superiority Study of Psilocybin-Assisted Acceptance and Commitment Therapy (ACT) in the Treatment of Treatment-resistant Anorexia Nervosa.","fullTitleTranslations":[],"publicTitle":"The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT)","publicTitleTranslations":[],"secondaryIdentifyingNumbers":{"additionalRegistries":[]}},"trialInformation":{"trialCategory":{"isLowIntervention":false,"trialPhase":"4","trialCategory":"2","justificationForTrialCategory":"The trial is a Phase II (Therapeutic exploratory)","trialCategoryId":127068},"medicalCondition":{"partIMedicalConditions":[{"id":144003,"medicalCondition":"Anorexia nervosa","medicalConditionTranslations":[],"isConditionRareDisease":false}]},"trialObjective":{"trialScopes":[{"code":"3","trialScopeId":418120}],"mainObjective":"To evaluate the effect of psilocybin on symptoms of anorexia nervosa.","mainObjectiveTranslations":[],"secondaryObjectives":[{"id":490881,"number":1,"secondaryObjective":"Evaluate the safety of psilocybin in anorexia nervosa","secondaryObjectiveTranslations":[]}]},"eligibilityCriteria":{"principalInclusionCriteria":[{"id":935597,"number":1,"principalInclusionCriteria":"Female gender","principalInclusionCriteriaTranslations":[]},{"id":935598,"number":2,"principalInclusionCriteria":"Between 18 and 50 years of age. Including both ages.","principalInclusionCriteriaTranslations":[]},{"id":935599,"number":3,"principalInclusionCriteria":"ICD-11 Anorexia Nervosa or Atypical Anorexia Nervosa diagnosis","principalInclusionCriteriaTranslations":[]},{"id":935600,"number":4,"principalInclusionCriteria":"No known allergy to any of the substances in the study medication","principalInclusionCriteriaTranslations":[]},{"id":935601,"number":5,"principalInclusionCriteria":"Suboptimally treated with current interventions as judged by investigator (at least one failed line of treatment with standard psychotherapy)","principalInclusionCriteriaTranslations":[]},{"id":935602,"number":6,"principalInclusionCriteria":"Able to discontinue psychopharmacological medication, except benzodiazepines and SSRI","principalInclusionCriteriaTranslations":[]}],"principalExclusionCriteria":[{"id":1598830,"number":1,"principalExclusionCriteria":"Current or previous history of psychotic symptoms","principalExclusionCriteriaTranslations":[]},{"id":1598831,"number":2,"principalExclusionCriteria":"First-degree relatives with a history of psychotic symptoms","principalExclusionCriteriaTranslations":[]},{"id":1598832,"number":3,"principalExclusionCriteria":"BMI ≤ 15","principalExclusionCriteriaTranslations":[]},{"id":1598833,"number":4,"principalExclusionCriteria":"Acute risk of suicidality","principalExclusionCriteriaTranslations":[]},{"id":1598834,"number":5,"principalExclusionCriteria":"Prior use of psychedelics (LSD, psilocybin, DMT) within the last two years","principalExclusionCriteriaTranslations":[]},{"id":1598835,"number":6,"principalExclusionCriteria":"Somatic comorbidity requiring systemic medications","principalExclusionCriteriaTranslations":[]},{"id":1598836,"number":7,"principalExclusionCriteria":"Epilepsy with history of seizures","principalExclusionCriteriaTranslations":[]},{"id":1598837,"number":8,"principalExclusionCriteria":"Prior use of psychedelics (LSD, psilocybin, DMT) within the last two years","principalExclusionCriteriaTranslations":[]}]},"endPoint":{"primaryEndPoints":[{"id":1093295,"number":1,"endPoint":"Baseline plus 10 weeks","isPrimary":true,"endPointTranslations":[]}],"secondaryEndPoints":[{"id":1093296,"number":1,"endPoint":"Baseline plus 22 weeks","isPrimary":false,"endPointTranslations":[]}]},"trialDuration":{"estimatedEndDate":"2029-12-31","estimatedRecruitmentStartDate":"2026-06-01"},"sourceOfMonetarySupport":[{"id":101176,"organisationName":"Novo Nordisk Foundation"}],"populationOfTrialSubjects":{"ageRanges":[{"id":378144,"ageRangeCategoryCode":"3","ageRangeCategory":"3"}],"ageRangeSecondaryIds":[],"clinicalTrialGroups":[{"code":"2","name":"Patients"}],"isFemaleSubjects":true,"isMaleSubjects":false,"isVulnerablePopulationSelected":false},"individualParticipantData":{"planToShareIPD":"3"}},"protocolInformation":{"studyDesign":{"periodDetails":[]}},"scientificAdviceAndPip":{"scientificAdvices":[],"paediatricInvestigationPlan":[]},"associatedClinicalTrials":[{"id":36138,"ctNumber":"2025-524939-39-00","sponsorName":"Slagelse Hospital","fullTitle":"The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT). A Randomised, Active-Placebo-Controlled, Triple-blind, Superiority Study of Psilocybin-Assisted Acceptance and Commitment Therapy (ACT) in the Treatment of Treatment-resistant Anorexia Nervosa.","sponsorAgreementOption":"NON_APPLICABLE","sponsorAgreementOptionName":"NON_APPLICABLE","parentClinicalTrialId":26751,"hasDocument":false,"associatedCtDocs":[]},{"id":36139,"ctNumber":"2025-524939-39-01","sponsorName":"Slagelse Hospital","fullTitle":"The Danish Anorexia Nervosa Psilocybin RCT (DANP-RCT). A Randomised, Active-Placebo-Controlled, Triple-blind, Superiority Study of Psilocybin-Assisted Acceptance and Commitment Therapy (ACT) in the Treatment of Treatment-resistant Anorexia Nervosa.","sponsorAgreementOption":"NON_APPLICABLE","sponsorAgreementOptionName":"NON_APPLICABLE","parentClinicalTrialId":28068,"hasDocument":false,"associatedCtDocs":[]}],"references":[],"pubmedCode":[],"pubmedUrl":[]},"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2026-07-22","conclusionDate":"2026-07-22","therapeuticAreas":[{"code":"33","name":"Psychiatry and Psychology [F] - Mental Disorders [F03]"}],"medicalConditions":[{"id":144003,"medicalCondition":"Anorexia nervosa","isConditionRareDisease":false}],"sponsors":[{"id":156608,"primary":true,"publicContacts":[{"id":462266,"type":"Public","functionalName":"Investigator","functionalEmailAddress":"ohov@regionsjaelland.dk","telephone":"41867567","organisation":{"id":921722,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Slagelse Hospital","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100030263","organisationLocationStatus":"Active"}}],"scientificContacts":[{"id":462267,"type":"Scientific","functionalName":"Investigator","functionalEmailAddress":"ohov@regionsjaelland.dk","telephone":"41867567","organisation":{"id":921722,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Slagelse Hospital","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100030263","organisationLocationStatus":"Active"}}],"thirdParties":[{"id":713302,"organisationAddress":{"id":969986,"organisation":{"id":1013430,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Region Hovedstaden","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100003705","organisationLocationStatus":"Active"},"address":{"addressId":1091496,"oneLine":"Nordre Fasanvej 57, 1st Floor Entrance 2","addressLine1":"Nordre Fasanvej 57","addressLine2":"1st Floor Entrance 2","addressLine3":"","addressLine4":"","city":"Frederiksberg","postcode":"2000","country":2009,"countryName":"Denmark"},"phone":"+4538635620","email":"gcp-enheden.bispebjerg-frederiksberg-hospitaler@regionh.dk","isBusinessKeyValidated":true,"businessKey":"ORG-100003705"},"sponsorDuties":[{"id":1106681,"code":"1"}],"phoneNumber":"+4538635620","email":"gcp-enheden.bispebjerg-frederiksberg-hospitaler@regionh.dk"}],"organisation":{"id":921722,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Slagelse Hospital","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100030263","organisationLocationStatus":"Active"},"addresses":[{"id":879708,"organisation":{"id":921722,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Slagelse Hospital","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100030263","organisationLocationStatus":"Active"},"address":{"addressId":981910,"oneLine":"Ingemannsvej 18","addressLine1":"Ingemannsvej 18","addressLine2":"","addressLine3":"","addressLine4":"","city":"Slagelse","postcode":"4200","country":2009,"countryName":"Denmark"},"isBusinessKeyValidated":true,"businessKey":"ORG-100030263"}],"isCommercial":false,"commercial":"Non-Commercial"}],"trialCategoryCode":"2","trialCategoryJustificationComment":"The trial is a Phase II (Therapeutic exploratory)","partOneTherapeuticAreas":[{"id":1206804,"therapeuticArea":{"code":"33","name":"Psychiatry and Psychology [F] - Mental Disorders [F03]"}}],"productRoleGroupInfos":[{"id":426205,"comments":"PEX010","miaNumber":"244/0575/18","productRoleCode":"1","productRoleName":"Test","products":[{"id":572967,"part1MpRoleTypeCode":"1","productDictionaryInfo":{"productPk":"13947476","productPharmForm":"CAPSULES","euMpNumber":"PRD13947476","prodAuthStatus":1,"prodName":"PEX010","pharmForm":"CAPSULES","activeSubstanceName":"DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL","euSubstNumber":"SUB267722","nameOrg":"REGION SJAELLAND","productSubstances":[{"productPk":"13947476","substancePk":"377754","nameOrg":"REGION SJAELLAND","substanceOrigin":"Specified Substance Group 1","actSubstOrigin":"Specified Substance Group 1","actSubstName":"DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL","substanceEvCode":"SUB267722"}],"activeSubstanceOtherDescriptiveName":""},"isPaediatricFormulation":false,"mpRoleInTrial":"1","orphanDrugEdit":false,"doseUom":"mg milligram(s)","maxDailyDoseAmount":"25","doseUomTotal":"mg milligram(s)","maxTotalDoseAmount":"50","maxTreatmentPeriod":2,"timeUnitCode":"1","evCode":"PRD13947476","miaNumber":"244/0575/18","devices":[],"characteristics":["2"],"routes":["ORAL"],"allSubstancesChemicals":false,"productName":"PEX010","jsonActiveSubstanceNames":"dry extract from psilocybe cubensis (15-25:1), extraction solvent: methanol","pharmaceuticalFormDisplay":"CAPSULES"}]}],"isLowIntervention":false},"authorizedPartsII":[{"id":324184,"mscId":60237,"mscInfo":{"id":60237,"clinicalTrialId":28779,"countryOrganisationId":2009,"reportingStatusCode":"Authorised","fromDate":"2026-07-20","toDate":"2026-07-20","isProposedRms":true,"countryName":"Denmark","organisationInfo":{},"firstDecisionDate":"2026-08-01","trialStatus":"Authorised","trialPeriod":[],"trialRecruitmentPeriod":[],"hasRecruitmentStarted":false,"activeTrialPeriod":{},"activeTrialRecruitmentPeriod":{},"isWillingAtDayThreeView":false,"clinicalTrialStatusHistory":[{"id":383532,"mscId":60237,"trialStatus":"Under evaluation","trialStatusDate":"2026-05-11T22:08:14.885"},{"id":456596,"mscId":60237,"trialStatus":"Authorised","trialStatusDate":"2026-08-01T02:10:00.177"}],"applicationTypeMsc":"1","mscName":"Denmark","assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-07-31","decision":"authorized_conditions","decisionDate":"2026-08-01"},"decisionDate":"2026-08-01","recruitmentSubjectCount":62,"trialSites":[{"id":2272129,"organisationAddressInfo":{"id":886867,"organisation":{"id":928903,"type":"Hospital/Clinic/Other health care facility","typeCode":"8","name":"Region Sjaelland","commercial":false,"isBusinessKeyValidated":true,"businessKey":"ORG-100023219","organisationLocationStatus":"Active"},"address":{"addressId":990370,"oneLine":"Sygehusvej 10","addressLine1":"Sygehusvej 10","addressLine2":"","addressLine3":"","addressLine4":"","city":"Roskilde","postcode":"4000","country":2009,"countryName":"Denmark"},"phone":"56531500","email":"suh@regionsjaelland.dk","isBusinessKeyValidated":true,"businessKey":"ORG-100023219"},"personInfo":{"id":2519445,"firstName":"Oliver","lastName":"Hovmand","telephone":"56531500","email":"suh@regionsjaelland.dk","title":"1"},"departmentName":"Psychiatric Research Unit"}],"applicationStatusCode":"Authorised"}],"applicationInfo":[{"id":83728,"type":"INITIAL","status":"Authorised","ctNumber":"2025-524939-39-02","trialStatus":"Authorised","submissionDate":"2026-05-11","partI":{"assessmentOutcome":"acceptable_conditions","assessmentOutcomeDate":"2026-07-22"},"partIIInfo":[{"id":324184,"mscId":60237,"mscInfo":{"id":60237,"mscName":"Denmark","countryOrganisationId":2009,"assessmentOutcome":"acceptable","assessmentOutcomeDate":"2026-07-31","decision":"authorized_conditions","decisionDate":"2026-08-01","reportingStatusCode":"Authorised","countryName":"Denmark","trialStatus":"Authorised","firstDecisionDate":"2026-08-01"},"applicationStatusCode":"Authorised"}],"decisionDate":"2026-08-01","ctMSCsByApplication":[{"id":60237,"mscName":"Denmark","reportingStatusCode":"Authorised"}],"businessKey":"IN-2","allPartTwosOutOfScope":false,"applicationTrialDecisionByMsc":{},"decisions":[{"id":135616,"applicationId":83728,"mscId":60237,"mscName":"Denmark","decisionDate":"2026-08-01T02:10:00.347","decision":"authorized_conditions","assessmentOutcome":"acceptable","eventType":"decision","part2Id":324184,"part1Id":137602,"applicationType":"INITIAL","isRMS":true}]}],"trialGlobalEnd":[],"memberStatesConcerned":[{"mscName":"Denmark","mscId":60237,"firstDecisionDate":"2026-08-01T02:10:00.347","lastDecisionDate":"2026-08-01T02:10:00.347","mscPublicStatusCode":2}],"eudraCt":{"isTransitioned":false}},"events":{"temporaryHaltList":[],"trialEvents":[{"mscId":60237,"mscName":"Denmark","events":[]}],"unexpectedEvents":[],"seriousBreaches":[],"urgentSafetyMeasures":[]},"results":{},"documents":[{"title":"DANP-RCT_protocol","uuid":"3d10c2aa-4369-48da-8b3c-4c1ab9febe95","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137602,"manualVersion":"1.3","systemVersion":"5"},{"title":"DANP-RCT_protocol_tt","uuid":"1b3408c1-8b9f-42ed-a8a7-73c054d33e50","documentType":"104","documentTypeLabel":"Protocol (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":137602,"manualVersion":"1.3","systemVersion":"3"},{"title":"Protocol_synopsis_DANP_RCT","uuid":"0e4ccb5f-b284-4562-ab04-96b37587be14","documentType":"7","documentTypeLabel":"Synopsis of the protocol (for publication)","languageCode":6,"fileType":"DOCX","associatedEntityId":137602,"manualVersion":"1","systemVersion":"1"},{"title":"Website_DANP ","uuid":"b8f98acf-07c5-46ea-8823-bc910c408c23","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1","systemVersion":"1"},{"title":"L2_information_leaflet_DANP","uuid":"35825ca2-800e-45cd-8d0f-b9152e2b6b27","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1.1","systemVersion":"2"},{"title":"K1_recruitmentarrengements_DANP ","uuid":"683cac92-d001-42ac-a76e-77f22ee1a930","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1.1","systemVersion":"2"},{"title":"DANP_poster","uuid":"9ca6f59e-fb74-49f8-baef-f1b39fa3c591","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1","systemVersion":"1"},{"title":"K1_recruitmentarrengements_DANP_tt","uuid":"d7c47d22-ce47-4e3c-ac53-b6aa17621173","documentType":"14","documentTypeLabel":"Recruitment arrangements (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1.3","systemVersion":"4"},{"title":"L3_infomed_consent_form_DANP","uuid":"002e6fd3-f98c-4f6b-98b5-3d1cac948774","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1","systemVersion":"1"},{"title":"Outcomes_DANP-RCT","uuid":"8acfdf7f-f71e-41c3-bb22-0b0ac2fa2f07","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1","systemVersion":"1"},{"title":"Dine_rettigheder_som_forsgsperson_i_forsg_med_medicin_Videnskabsetik","uuid":"66791d91-3309-4423-bc57-bd57d15a51cc","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1","systemVersion":"1"},{"title":"L2_information_leaflet_DANP","uuid":"5ca5e110-4427-4e2d-9579-58c009f12a5a","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1.3","systemVersion":"4"},{"title":"L2_information_leaflet_DANP_tt","uuid":"63419acd-c55d-4f0e-9682-a329a7c3afa7","documentType":"15","documentTypeLabel":"Subject information and informed consent form (for publication)","languageCode":6,"fileType":"PDF","associatedEntityId":324184,"manualVersion":"1.2","systemVersion":"3"}],"trialRegion":"EEA","trialRegionCode":1,"correctiveMeasures":[]}